investors.ginkgobioworks.com
Ginkgo Bioworks and XpresCheck Expand CDC's Traveler-Based Genomic Surveillance Program to Detect...
The program is an effective early warning system for viral variants, leveraging voluntary sampling from international travelers at major U.S. airports Ginkgo Bioworks (NYSE: DNA) and XWELL, Inc....